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ABSTRACT
Measuring thyroid hormones is an important aspect for the study of metabolism and for monitoring 
diseases in both human and animal models. The traditional method for hormone measurement in rats 
is the radioimmunoassay (RIA). However, the RIA is associated with some practical disadvantages, 
including the use of radioactive material, the need for specialized equipment and expert staff, the 
short shelf-life of kits according to the half-life of the radioisotope and high costs. The objective of this 
study was to develop a new cost-effective method for measuring TSH levels in rats that avoids the 
use of radioactive material. We developed an in-house competitive immunoassay using a reference 
standard, polyclonal antibody produced in rabbits and biotinylated antigen. This method was tested 
in 64 Wistar rats that were divided into a control group (n = 41) and a group with hypothyroidism 
(n = 23). Our assay demonstrated an analytical sensitivity of 0.24 ng/mL (n = 12) and an intra-assay 
coefficient of variation (CV) of 8.9% for sera with TSH levels of 1.5 ng/mL and 13.2% for sera with 
TSH levels of 17.5 ng/mL (n = 14). The inter-assay CV was 13.5% for sera with TSH levels of 1.4 ng/
mL and 14.5% for TSH levels of 18.2 ng/mL (n = 5). The analysis of mean TSH levels in control rats 
(5.06 ± 0.5701) and hypothyroid rats (51.09 ± 5.136) revealed a statistically significant difference (p < 
0.001) between the groups. This method showed good sensitivity, can be automated and is low-cost 
compared with RIA. Our method offers a viable alternative for TSH measurement in rats. Arch Endocrinol 
Metab. 2017;61(5):460-3
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INTRODUCTION
H ormone measurement is an important component for the study of metabolism, analysis 
of diseases and as a parameter of health assessments. 
Of the different hormone assays, immunological assays 
have become standard due to several advantages: they 
offer great specificity and potentially high sensitivity 
and present with ease of use and wide-ranging 
applications (1). Immunological assays are largely used 
for measuring biologically active compounds present 
in low concentrations, such as hormones, proteins, 
drugs and microorganisms. In this context, the most 
commonly used techniques are radioactively labeled 
competitive and non-competitive immunoassays (RIA, 
IRMA), which are highly sensitive and precise but 
are also associated with several disadvantages. Among 
the drawbacks, the use of radioactive tracers is of 
most concern because they present a health hazard, 
require special attention for handling, well-trained staff 
and well-defined waste storage. Moreover, because 
radioisotopes have a limited half-life, kits have limited 
shelf lives, and radioactive counting can be time-
consuming and requires expensive instrumentation. 
Because of these issues, alternative immunoassays 
(competitive or non-competitive) have been developed 
using alternative labels such as enzymes (EIA, ELISA), 
luminescent compounds, fluorescent probes (IFMA, 
FIA) and metals. Assays that use alternative tracers 
offer similar or better sensitivity than that of IRMA 
and RIA. Importantly, avoidance of radiation is a major 
advantage.
Several immunoassays for measuring hormones 
have been described, and the most commonly used 
technique for the measurement of rat serum is the 
radioimmunoassay (RIA), which is associated with 
the disadvantages described above (2). In addition, 
commercial kits are costly, and their shelf life depends 
on the half-life of the radioisotope. Therefore, 
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development of new assays that do not use radioisotopes 
is needed.
MATERIALS AND METHODS
Assay development
We developed an in-house competitive immunoassay 
using rat TSH extracted from pituitary gland as a 
standard, polyclonal antibody produced in rabbits 
against rat TSH and biotinylated TSH from the same 
source (National Institute of Diabetes & Digestive & 
Kidney Diseases, NIDDK). Rat thyroid-stimulating 
hormone was prepared at a concentration of 50 µg/mL, 
after which it was biotinylated using the EZ-link-Sulfo-
NHS-LC-Biotin kit according to the manufacturer’s 
protocol (Thermo Scientific). A six-value curve was 
constructed from serial dilution of standard rat TSH in 
bovine fetal serum at the following concentrations: 100, 
25, 6.25, 1.56, 0.39 and 0 ng/mL. The standards, rat 
sera used as controls and test samples were incubated 
with a rabbit polyclonal antibody provided by NIDDK. 
After 24 h of incubation at 4°C, biotinylated TSH was 
added to tubes at a dilution of 1:1000. After another 
24 h incubation at 4°C, samples were transferred to 
a microtiter plate (Fluoronunc, Nunc, Roskilde, 
Denmark) that was previously adsorbed with an anti-
rabbit IgG monoclonal antibody (D4P4) produced by 
our laboratory (monoclonal antibody, 2 µg/well). After 
a 4-h incubation at room temperature and subsequent 
washing (Tris-HCl 50 mM with 0.5% BSA and 0.1% 
gamma-globulin), a solution of streptavidin-europium 
was added (200 µL/well). Finally, after incubation 
for 30 min at room temperature, plate was washed 12 
times with buffer, and an enhancement solution was 
added (200 µL/well, Delfia Enhancement Solution, 
Perkin-Elmer, Turku, Finland). The plate was then read 
by time-synchronized fluorometry in a Victor3 time-
resolved fluorometer (Perkin-Elmer, Turku, Finland). 
The amount of analyte was calculated based on the 
standard curve, and the results are expressed in ng/mL.
Animals
To test our method, we measured the serum TSH 
levels of 64 adult male Wistar rats (200-250 g) from 
the animal facility of the Institute of Pharmacology 
of Unifesp (Infar). Rats were kept under standard 
conditions for temperature (25 ± 1°C) and light/dark 
cycle (12/12 hours per day). Drinking water and food 
were provided ad libitum. Animals were divided into 
two experimental groups: a control group and a group 
with hypothyroidism. The hypothyroidism group 
consisted of 23 animals that were subjected to total 
thyroidectomy followed by methimazole treatment 
for 20 days. The control group consisted of 41 rats 
subjected to sham surgery.
Statistical analysis
All results are presented as mean values ± standard 
error of the mean. Statistical analysis was performed 
in Graph Pad Prism® version 5 software for Windows. 
First, the Shapiro-Wilk normality test was performed to 
verify normality of the distribution of the two sample 
groups. Non-parametric distribution was observed in 
the two groups, and thus a Mann-Whitney test was 
used to compare control and hypothyroidism groups. 
For all analyses, a significance threshold of p < 0.05 was 
assumed.
Ethics
All procedures were performed in accordance with 
the Brazilian College of Animal Experimentation and 
were approved by the Bioethical Commission of the 
Universidade Federal de São Paulo (Unifesp) (protocol 
number 5097101316).
RESULTS
Analytical sensitivity was determined using TSH 
stripped fetal bovine serum (FBS). FBS was measured 
multiple times, from which we calculated mean 
and standard deviation. Sensitivity was defined by 
the concentration corresponding to the mean - 2 
standard deviations of the latter measurements. A 
95% confidence interval was obtained, and the limit 
was defined by doubling the standard deviation. The 
new assay showed sensitivity of 0.24 ng/mL (n = 12). 
Intra-assay CV was 8.9% for sera with TSH levels of 
1.5 ng/mL and 13.2% for sera with TSH levels of 17.5 
ng/mL (n = 14). Inter-assay CV was 13.5% for sera 
with TSH levels of 1.4 ng/mL and 14.5% for sera with 
TSH levels of 18.2 ng/mL (n = 5). The values in the 
control rats ranged between 0.81 and 19.50 ng/mL, 
whereas the values in hypothyroid rats ranged between 
15 and > 100 ng/mL.
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Linearity of our assay was tested by serial dilution of 
a hypothyroid rat serum (36 ng/mL), which produced 
a value of R2 = 0.97. The analysis of mean TSH obtained 
from control rat sera (5.06 ± 0.5701) and hypothyroid 
rat sera (51.09 ± 5.136) showed statistically significant 
differences (p < 0.001) between the groups.
To verify cross-reaction with the antibody used 
in our test, sera from different species were tested: 
FBS, mouse, rabbit, horse and primate. Rabbit serum 
interferes significantly in the assay, although sheep and 
horse also have some interference, generating a lower 
reading signal. Then, we used standard TSH to create 
curves using these different matrices, to identify if 
assay sensitivity could be improved. Curves in FBS and 
in buffer with 5% BSA are the most sensitive, although 
FBS remains the best matrix since, in buffer, the 
curve is slightly shifted to the right, indicating lower 
analytical sensitivity. Horse and sheep sera are much 
less sensitive (data not shown).
As a recovery test we used three sera samples with 
different TSH concentrations and added 50 ng of the 
standard in the two matrices. 
including endocrinology (3). Therefore, more sensitive 
and specific tests in animal field could increase the 
frequency of testing and, consequently, detection of 
thyroid conditions, with the possibility of detecting 
degrees of thyroid dysfunction in research animals.
In this study, we developed a new solid-phase 
fluorometric immunoassay for measuring TSH in 
rats that does not use radioactive material. The lack 
of radioactive material offers a considerable advantage 
because handling radioactive material presents a health 
hazard for researchers, and the assay shelf life is not 
constrained by the half-life of the radioisotope. Our 
method shows good sensitivity, can be automated, 
and with its low operational cost offers considerable 
advantages compared with traditional RIA methods. 
Additionally, as NIDDK reagents are the same as those 
used in the traditional RIA, following recommendations 
in ATA Guidelines for thyroid hormone investigation 
in rodents and cell models (2), this assay can be 
compared with available data in the literature.
However, our method has some limitations. In 
recovery test, all samples recovered above the expected 
(data not shown). One reason that should be taken in 
consideration is the fact that the standard originates 
from rat pituitary. Unfortunately, there is no source of 
rat serum TSH to use as the standard for assembling 
the immunoassay, forcing us to use pituitary TSH. The 
antibody used in the assay was also produced against 
pituitary TSH, and, probably, recognizing it more 
specifically and with greater affinity than serum TSH. 
For this reason, the assay shows high recovery. This is 
a limitation of experimental design, since all the assay 
reagents are derived from pituitary TSH, that has a 
different immunogenic structure than rat serum TSH.
More studies measuring TSH levels in rats with 
hyperthyroidism should be conducted. Nevertheless, 
the method described here offers an effective alternative 
for TSH measurement in rats.
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Figure 1. Mean TSH levels (± SEM) measured using a novel 
fluoroimmunoassay in 41 control and 23 rats with hypothyroidism. Dashed 
line indicates the lower limit of detection of the assay.
DISCUSSION
Measurement of TSH levels is useful for clinical 
evaluation of human patients, as small changes in free 
thyroid hormone levels lead to greater changes in TSH 
levels. Serum TSH is considered the single most reliable 
diagnostic test for all common forms of hypothyroidism 
and hyperthyroidism. Animal research has played a 
vital part in medical and biomedical research and has 
led to important scientific discoveries in many fields, 
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